Company Pay Ratios
Publicly traded companies are required to disclose the pay ratio between their chief executive officers and median employees. High CEO-to-worker pay ratios contribute to economic inequality and can undermine employee morale and productivity. The average S&P 500 company’s CEO-to-worker pay ratio was 272-to-1 in 2022.
| Ticker | Company | Median Worker Pay Sort descending | Pay Ratio |
|---|---|---|---|
| PBYI | Puma Biotechnology, Inc. | $243,139 | 10:1 |
| LXRX | Lexicon Pharmaceuticals, Inc. | $243,342 | 17:1 |
| BSIG | Brightsphere Investment Group Inc. | $243,450 | 3:1 |
| SCU | Sculptor Capital Management, Inc. | $243,652 | 201:1 |
| ICPT | Intercept Pharmaceuticals, Inc. | $243,657 | 18:1 |
| GTHX | G1 Therapeutics, Inc. | $243,930 | 12:1 |
| AVDL | Avadel Pharmaceuticals PLC | $244,878 | 3:1 |
| EGRX | Eagle Pharmaceuticals, Inc. | $245,274 | 43:1 |
| XPER | Adeia Inc. | $246,490 | 48:1 |
| WETF | Wisdomtree, Inc. | $246,806 | 22:1 |
| VRTS | Virtus Investment Partners, Inc. | $246,948 | 26:1 |
| TBPH | Theravance Biopharma, Inc. | $247,108 | 25:1 |
| INCY | Incyte Corp. | $247,678 | 67:1 |
| ETSY | Etsy Inc. | $248,232 | 66:1 |
| XHR | Xenia Hotels & Resorts, Inc. | $248,639 | 29:1 |
| RDUS | Radius Health, Inc. | $248,946 | 14:1 |
| ENTA | Enanta Pharmaceuticals Inc. | $249,345 | 29:1 |
| SRPT | Sarepta Therapeutics, Inc. | $249,890 | 494:1 |
| NGM | Ngm Biopharmaceuticals Inc. | $251,078 | 24:1 |
| OHI | Omega Healthcare Investors Inc. | $251,150 | 44:1 |
NOTE: For companies with more than one CEO during the year, the highest-paid CEO is included in the database. Pay ratio between CEO pay and median employee pay are displayed as disclosed by each company’s proxy statement. The CEO pay ratio may not equal the displayed CEO’s total compensation due to differing company methodologies in calculating pay ratios.
Terms and Data Sources | Contact the Press Office